About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Society of Hematologic Oncology
Free SOHO Membership:
www.sohoonline.org
SOHO 2023
Leukemia
Lymphoma
Myeloma
MDS and MPN
Videos
SOHO 2022
Myeloma
Lymphoma
Leukemia
MDS and MPN
Benign Hematology
SOHO 2021
Myeloma
Cellular Therapy
Solid Tumors
Leukemia
MDS
Benign Hematology
MPN
Lymphoma
SOHO 2020
Basic Science
Lymphoma
Leukemia
Myeloma
MDS and MPN
Benign Hematology
SOHO Highlights: State of the Art and Next Questions
SOHO 2019
Hodgkin Lymphoma
Multiple Myeloma
Chronic Lymphocytic Leukemia
Meet The Professor Sessions
Chronic Myeloid Leukemia
Myeloproliferative Neoplasms
Breakfast With The Expert
Independent Satellite Symposium
Plenary Sessions
Evolving Practices in AML: A Case-based Guide to New and Emerging Treatment Options
Acute Lymphoblastic Leukemia
Myelodysplastic Syndromes
Acute Myeloid Leukemia
Indolent B-cell Lymphoma
Mantle Cell Lymphoma
Aggressive B-cell Lymphoma
T-cell Lymphoma
Cellular Therapy
Next Questions
SOHO 2018
Session I: Chronic Myeloid Leukemia
Session II: Myelodysplastic Syndromes
Session III: Myeloproliferative Neoplasms
Session IV: Acute Lymphoblastic Leukemia
Session V: Acute Myeloid Leukemia
Session VI: Multiple Myeloma
Session VIII: Non-Hodgkin Lymphoma
Session IX: Chronic Lymphocytic Leukemia
Session X: Research Topics
Plenary Sessions
Breakfast with the Expert
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
V
2020 SOHO Update on MDS: Characteristics and Outcomes of SF3B1 Mutation in t-MDS vs. De Novo MDS, SF3B1 Mutation vs. SF3B1-WT in Therapy Related MDS
By
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
FEATURING
Virginia Volpe
By
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
FEATURING
Virginia Volpe
156 views
December 11, 2020
0 Comments
Login to view comments.
Click here to Login
Featured Video
24:44
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignan…
Feat.
R. Birhiray
Featured Video
24:35
Indy Hematology Review
Current Approaches in the Treatment of Myeloproliferative Neoplasms
Feat.
A. Tefferi
MDS and MPN
09:07
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Update on MDS: Characteristics and Outcomes of SF3B1 Mutat…
Feat.
V. Volpe
14:48
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Update on IDH Inhibitors in MDS: How Common Are IDH 1/2 Mu…
Feat.
C. DiNardo
13:30
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Updates on Anemia in MDS: How Does Luspatercept Affect RBC…
Feat.
U. Platzbecker
15:33
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Updates on Oral HMAs in MDS: Can FDA-Approved Decitabine/C…
Feat.
G. Garcia-Manero
15:52
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Updates on MDS: What Is the Safety and Efficacy of Ven+Aza…
Feat.
A. Zeidan
17:02
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Updates on TP53 in MDS: What Is the Correlation of VAF and…
Feat.
D. Sallman
18:11
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Updates on MDS: How Do TP53 Mutations Impact Prognosis in …
Feat.
D. Sallman
19:05
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Updates on ET: What Does the Diagnostic Algorithm Look Lik…
Feat.
A. Tefferi
09:44
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
Next Questions in MF in 2020: What Is MIPSS70-Plus Risk Score? What …
Feat.
P. Bose
10:10
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Updates on MDS: What Is the Proposed Treatment Algorithm f…
Feat.
G. Garcia-Manero
16:23
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Highlights on Myelofibrosis: What Is the Distinctive Featu…
Feat.
R. Rampal
12:50
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Highlights on Myelofibrosis: How Can We Improve Survival A…
Feat.
U. Popat
09:59
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Updates on Myelofibrosis: What Are the Long-Term Outcomes …
Feat.
J. Joseph
17:07
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
73 y/o Male With Polycythemia Vera With JAK2 V617F Mutation: How Doe…
Feat.
L. Michaelis
15:11
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
34 y/o Female With JAK2 V617F Mutated Polycythemia Vera: What PV Tre…
Feat.
G. Hobbs
16:58
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Updates on Myelofibrosis: What Are the Response Rates With…
Feat.
S. Verstovsek
